HOLTUG LARS

SEC Form 4 insider trading activity

HOLTUG LARS has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.

On the most recent filing, HOLTUG LARS is listed as Director at Ascendis Pharma A/S. Inside the rolling window, HOLTUG LARS reported no open-market purchases and 1 open-market sale totaling $62K in ASND.

Companies traded

Other insiders at ASND

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$62K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ASND
HOLTUG LARS
Sale$62KSep 3SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has HOLTUG LARS made?

HOLTUG LARS has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.

Which companies does HOLTUG LARS trade?

HOLTUG LARS has filed SEC Form 4 disclosures for 1 company, including ASND.

When was HOLTUG LARS's most recent SEC Form 4 filing?

HOLTUG LARS's most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.

What is HOLTUG LARS's total buy and sell value in the current window?

Inside the rolling retention window, HOLTUG LARS bought $0 and sold $62K based on SEC Form 4 filings.

What was HOLTUG LARS's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 236 ASND shares on 2026-09-02, worth $62K, per SEC Form 4 filings.